Table 2.
Single and mixed infection of CVBD pathogens from 48 dogs (group 1: clinically suspected of vector-borne diseases) and 94 dogs (group 2: apparently healthy)
| Pathogens | No. positive dogs (%) | DDBJ accessions | BLAST matching | |
|---|---|---|---|---|
| Group 1 (n = 48) |
Group 2 (n = 94) |
|||
| Single infections | 6 (12.5%; CI 5.9–24.7) | 25 (26.6%; CI 18.7–36.3%) | ||
| Babesia canis | 2 (4.2%; CI 1.2–14.0) | – | MT821184 | KY359360 100% |
| Babesia vogeli | 1 (2.1%; CI 0.4–10.9) | 3 (3.2%; CI 1.1–9.0%) | MT821127 |
100% |
| Hepatozoon canis | 4 (8.3%; 3.3–19.6) | 13 (13.9%; CI 8.3–22.2%) | MT821480 |
99.66% |
| Mycoplasma haemocanis | 1 (2.1%; CI 0.4–10.9) | 6 (6.4%; CI 3.0–13.2%) | MT816510 |
100% |
| Anaplasma platys | 1 (2.1%; CI 0.4–10.9) | 3 (3.2%; CI 1.1–9.0%) | MT815595 |
100% |
| Ehrlichia canis | – | 1 (1.1%; CI 0.2–5.8%) | MT815600 | MN922610 100% |
| Co-infections | 1 (2.1%; CI 0.4–10.9) | 12 (12.8%; CI 7.5–21.0%) | ||
| Hepatozoon canis + Anaplasma platys | 1 (2.1%; CI 0.4–10.9) | 4 (4.3%; CI 1.7–10.4%) | ||
| Hepatozoon canis + Mycoplasma haemocanis | – | 5 (5.3%; CI 2.3–11.8%) | ||
| Hepatozoon canis + Mycoplasma haematoparvum | – | 2 (2.1%; CI 0.6–7.4%) | MT816509 |
100% |
| Anaplasma platys + Mycoplasma heamatoparvum | – | 1 (1.1%; CI 0.6–7.4%) | ||
n: total number